Target type: biologicalprocess
The directed movement of inorganic anions from outside of a cell, across the plasma membrane and into the cytosol. [GOC:dos]
Inorganic anion import across the plasma membrane is a crucial process for cellular homeostasis and function. It involves the movement of negatively charged ions, such as chloride (Cl-), bicarbonate (HCO3-), phosphate (PO43-), and sulfate (SO42-), from the extracellular environment into the cell. This process is facilitated by a variety of membrane transport proteins, including ion channels, transporters, and pumps.
Ion channels are highly selective pores that allow the passive movement of ions down their electrochemical gradient. Some ion channels are specifically designed for anion transport, such as chloride channels, which play a critical role in regulating cell volume, nerve impulse transmission, and pH balance.
Transporters, on the other hand, bind to anions and move them across the membrane through a conformational change. These transporters can be either uniporters, which move a single type of anion across the membrane, or cotransporters, which couple the movement of an anion to the movement of another molecule, such as a proton or a sodium ion.
Pumps, unlike channels and transporters, require energy to move anions against their electrochemical gradient. This energy is often derived from ATP hydrolysis. An example of an anion pump is the Na+/K+ ATPase, which actively pumps sodium ions out of the cell and potassium ions into the cell, indirectly contributing to anion transport.
The specific mechanism of anion import can vary depending on the type of anion, the cell type, and the physiological conditions. For instance, chloride import is crucial for maintaining cell volume and regulating neuronal excitability. Bicarbonate import is essential for pH homeostasis and carbon dioxide transport. Phosphate import is vital for energy metabolism and nucleic acid synthesis. Sulfate import is necessary for protein synthesis and detoxification.
The import of inorganic anions is tightly regulated to ensure that intracellular ion concentrations are maintained within optimal ranges. This regulation involves a complex interplay of factors, including membrane potential, intracellular ion concentrations, and the activity of various transporter proteins.
In summary, inorganic anion import across the plasma membrane is a complex and essential process that involves a variety of transport proteins, including ion channels, transporters, and pumps. This process is vital for maintaining cell homeostasis, regulating cell function, and ensuring the proper functioning of various physiological processes.'
"
Protein | Definition | Taxonomy |
---|---|---|
Solute carrier family 12 member 2 | A solute carrier family 12 member 2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P55011] | Homo sapiens (human) |
Sodium- and chloride-dependent GABA transporter 1 | A sodium- and chloride-dependent GABA transporter 1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P30531] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
gamma-aminobutyric acid | gamma-aminobutyric acid : A gamma-amino acid that is butanoic acid with the amino substituent located at C-4. gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system. | amino acid zwitterion; gamma-amino acid; monocarboxylic acid | human metabolite; neurotransmitter; Saccharomyces cerevisiae metabolite; signalling molecule |
2,3-diaminopropionic acid | 3-aminoalanine : A diamino acid that is alanine in which one of the hydrogens of the methyl group is replaced by an amino group. | alanine derivative; amino acid zwitterion; beta-amino acid; diamino acid; non-proteinogenic alpha-amino acid | Escherichia coli metabolite |
bumetanide | amino acid; benzoic acids; sulfonamide | diuretic; EC 3.6.3.49 (channel-conductance-controlling ATPase) inhibitor | |
guvacine | guvacine : A alpha,beta-unsaturated monocarboxylic acid that is nicotinic acid which has been hydrogenated at the 1-2 and 5-6 positions of the pyridine ring. guvacine: RN given refers to parent cpd | alpha,beta-unsaturated monocarboxylic acid; beta-amino acid; pyridine alkaloid; secondary amino compound; tetrahydropyridine | GABA reuptake inhibitor; plant metabolite |
nipecotic acid | nipecotic acid : A piperidinemonocarboxylic acid that is piperidine in which one of the hydrogens at position 3 is substituted by a carboxylic acid group. nipecotic acid: RN given refers to cpd without isomeric designation | beta-amino acid; piperidinemonocarboxylic acid | |
tiagabine | tiagabine : A piperidinemonocarboxylic acid that is (R)-nipecotic acid in which the hydrogen attached to the nitrogen has been replaced by a 1,1-bis(3-methyl-2-thienyl)but-1-en-4-yl group. A GABA reuptake inhibitor, it is used (generally as the hydrochloride salt) for the treatment of epilepsy. Tiagabine: A nipecotic acid derivative that acts as a GABA uptake inhibitor and anticonvulsant agent. It is used in the treatment of EPILEPSY, for refractory PARTIAL SEIZURES. | beta-amino acid; piperidinemonocarboxylic acid; tertiary amino compound; thiophenes | anticonvulsant; GABA reuptake inhibitor |
tiagabine hydrochloride | tiagabine hydrochloride : A hydrochloride resulting from the reaction of equimolar amounts of tiagabine and hydrogen chloride. A GABA reuptake inhibitor, it is used for the treatment of epilepsy. | hydrochloride | anticonvulsant; GABA reuptake inhibitor |
n-(4,4-diphenyl-3-butenyl)nipecotic acid | N-(4,4-diphenyl-3-butenyl)nipecotic acid: structure given in first source | diarylmethane | |
nnc 711 | NNC 711: structure in first source | ||
sk&f 100330-a | SK&F 100330-A: structure given in first source | ||
ci 966 | CI 966: GABA uptake blocker; RN from Toxlit | diarylmethane | |
hinokinin | hinokinin : A lignan that is dihydrofuran-2(3H)-one (gamma-butyrolactone) substituted by a 3,4-methylenedioxybenzyl group at positions 3 and 4 (the 3R,4R-diastereoisomer). hinokinin: suppresses expression of both HBsAg and HBeAg | benzodioxoles; gamma-lactone; lignan | trypanocidal drug |
n-(1-benzyl-4-piperidinyl)-2,4-dichlorobenzamide | N-(1-benzyl-4-piperidinyl)-2,4-dichlorobenzamide: inhibits the betaine-GABA transporter 1; structure in first source | ||
nipecotic acid | (R)-nipecotic acid : The (R)-enantiopmer of nipecotic acid. | amino acid zwitterion; nipecotic acid | |
nipecotic acid, (s)-isomer | (S)-nipecotic acid : The (S)-enantiomer of nipecotic acid. | nipecotic acid | |
n-(4-methylthiazol-2-yl)-2-(6-phenylpyridazin-3-ylthio)acetamide | N-(4-methylthiazol-2-yl)-2-(6-phenylpyridazin-3-ylthio)acetamide: a KCC2 cotransporter antagonist | pyridazines; ring assembly | |
2-ethoxy-N-[1-(phenylmethyl)-4-piperidinyl]benzamide | piperidines | ||
nnc 05-2090 | NNC 05-2090: structure given in first source | carbazoles | |
snap 5114 |